Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of the study is to follow the management of blood lipids in patients with planned percutaneous coronary intervention (widening of coronary vessels) in a period from 6 to 10 weeks after the intervention.
Epistemonikos ID: 55870fce9edb1cd55e7571acf172677b3e99dc98
First added on: May 05, 2024